LB-8 | Performance and Use of the Evolut FX Transcatheter Aortic Valve System: Updated Results from the Evolut FX Limited Market Release Clinical Survey
Tanvir Bajwa(Aurora Health Care), Gilbert H.L. Tang(Mount Sinai Health System), George Petrossian, Guilherme F. Attizzani(Université Claude Bernard Lyon 1), Mathew Rulon Williams(Hinge Health), Stanley Chetcuti(University of Michigan), Mustafa I. Ahmed(National and Kapodistrian University of Athens), Hemal Gada(University of Pittsburgh Medical Center), L. Lambrecht(Medtronic (Ireland)), Matthew D. Saybolt(Jersey Shore University Medical Center)
Journal of the Society for Cardiovascular Angiography & Interventions
May 1, 2023
Cited by 2
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k
Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2008|832
Acute and 12-Month Results With Catheter-Based Mitral Valve Leaflet Repair
|Journal of the American College of Cardiology|2012|567
4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
|Journal of the American College of Cardiology|2013|444